4V5

2-deoxy-2-{[3-(4-hydroxyphenyl)propanoyl]amino}-alpha-D-glucopyranose

Created:	2015-06-04
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where 4V5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	5
Bond Count	45
Aromatic Bond Count	6

2D diagram of 4V5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-deoxy-2-{[3-(4-hydroxyphenyl)propanoyl]amino}-alpha-D-glucopyranose
Synonyms	N-[3-(4-hydroxyphenyl)propanoyl]-alpha-D-glucosamine; 2-deoxy-2-{[3-(4-hydroxyphenyl)propanoyl]amino}-alpha-D-glucose; 2-deoxy-2-{[3-(4-hydroxyphenyl)propanoyl]amino}-D-glucose; 2-deoxy-2-{[3-(4-hydroxyphenyl)propanoyl]amino}-glucose
Systematic Name (OpenEye OEToolkits)	N-[(2S,3R,4R,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]-3-(4-hydroxyphenyl)propanamide
Formula	C₁₅ H₂₁ N O₇
Molecular Weight	327.33
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c2cc(CCC(NC1C(C(C(OC1O)CO)O)O)=O)ccc2O
SMILES	CACTVS	3.385	OC[CH]1O[CH](O)[CH](NC(=O)CCc2ccc(O)cc2)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.9.2	c1cc(ccc1CCC(=O)NC2C(C(C(OC2O)CO)O)O)O
Canonical SMILES	CACTVS	3.385	OC[C@H]1O[C@H](O)[C@H](NC(=O)CCc2ccc(O)cc2)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1cc(ccc1CCC(=O)N[C@@H]2[C@H]([C@@H]([C@H](O[C@@H]2O)CO)O)O)O
InChI	InChI	1.03	InChI=1S/C15H21NO7/c17-7-10-13(20)14(21)12(15(22)23-10)16-11(19)6-3-8-1-4-9(18)5-2-8/h1-2,4-5,10,12-15,17-18,20-22H,3,6-7H2,(H,16,19)/t10-,12-,13-,14-,15+/m1/s1
InChIKey	InChI	1.03	WKSQEORRFJBWEH-GZENYHORSA-N

Related Resource References

Resource Name	Reference
PubChem	91801173

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.